PL101299B1 - Sposob wytwarzania pochodnych kwasu fenyloalkanokarboksylowego - Google Patents

Sposob wytwarzania pochodnych kwasu fenyloalkanokarboksylowego Download PDF

Info

Publication number
PL101299B1
PL101299B1 PL1976188879A PL18887976A PL101299B1 PL 101299 B1 PL101299 B1 PL 101299B1 PL 1976188879 A PL1976188879 A PL 1976188879A PL 18887976 A PL18887976 A PL 18887976A PL 101299 B1 PL101299 B1 PL 101299B1
Authority
PL
Poland
Prior art keywords
phenyl
acid
ethyl
melting point
propionic acid
Prior art date
Application number
PL1976188879A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19752517229 external-priority patent/DE2517229A1/de
Priority claimed from DE19762604560 external-priority patent/DE2604560A1/de
Application filed filed Critical
Publication of PL101299B1 publication Critical patent/PL101299B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
PL1976188879A 1975-04-18 1976-04-17 Sposob wytwarzania pochodnych kwasu fenyloalkanokarboksylowego PL101299B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19752517229 DE2517229A1 (de) 1975-04-18 1975-04-18 Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
DE19762604560 DE2604560A1 (de) 1976-02-06 1976-02-06 Phenylalkancarbonsaeure-derivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
PL101299B1 true PL101299B1 (pl) 1978-12-30

Family

ID=25768786

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1976188879A PL101299B1 (pl) 1975-04-18 1976-04-17 Sposob wytwarzania pochodnych kwasu fenyloalkanokarboksylowego

Country Status (23)

Country Link
US (1) US4113871A (enExample)
JP (1) JPS51136646A (enExample)
AR (1) AR213174A1 (enExample)
AT (1) AT345795B (enExample)
AU (1) AU497513B2 (enExample)
BG (1) BG26518A3 (enExample)
CA (1) CA1047513A (enExample)
DD (1) DD124974A5 (enExample)
DK (1) DK148576A (enExample)
ES (1) ES446976A1 (enExample)
FI (1) FI761004A7 (enExample)
FR (1) FR2307528A1 (enExample)
GB (1) GB1484848A (enExample)
HU (1) HU177559B (enExample)
IE (1) IE42712B1 (enExample)
IL (1) IL49411A (enExample)
LU (1) LU74786A1 (enExample)
NL (1) NL7603947A (enExample)
PL (1) PL101299B1 (enExample)
PT (1) PT65019B (enExample)
RO (1) RO73520A (enExample)
SE (1) SE423231B (enExample)
SU (1) SU618038A3 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2532420A1 (de) * 1975-07-19 1977-02-03 Boehringer Mannheim Gmbh Phenylessigsaeure-derivate und verfahren zu ihrer herstellung
LU79008A1 (de) * 1978-02-03 1979-09-06 Byk Gulden Lomberg Chem Fab W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel
IT1121577B (it) * 1979-06-14 1986-04-02 Wassermann Spa A Procedimento per la produzione di carbossammido-etilbenzen-4-4solfonammidi
DE3062216D1 (en) * 1979-09-06 1983-04-07 Beecham Group Plc Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US4413011A (en) * 1981-02-26 1983-11-01 Warner-Lambert Company Substituted 2,2-dimethyl-5-phenoxypentanoic acid benzamides as anti-arteriosclerotic agents and method
PT77219B (fr) * 1982-08-24 1986-02-04 May & Baker Ltd Procede de preparation des derives de la benzamide
IT1177966B (it) * 1984-08-14 1987-09-03 Medosan Ind Biochimi Derivati amidici dell'acido 2-(p-aminobenzil)butirrico e relativi e-steri provvisti di attivita' ipolipidemizzante
US4689182A (en) * 1985-12-20 1987-08-25 Warner-Lambert Company Benzoic acid and benzoic acid ester derivatives having anti-inflammatory and analgesic activity
CA2057324A1 (en) * 1990-12-18 1992-06-19 Lora Louise Fitch Benzamide and sulfonamide hypoglycemic agents
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5741926A (en) * 1997-02-12 1998-04-21 Shaman Pharmaceuticals, Inc. Aniline derivatives having antihyperglycemic activity
RU2176999C2 (ru) * 1997-10-02 2001-12-20 Санкио Компани, Лимитед Производные амидокарбоновой кислоты, фармацевтическая композиция на их основе и способ снижения глюкозы в крови
JP4618845B2 (ja) * 1999-06-09 2011-01-26 杏林製薬株式会社 ヒトペルオキシゾーム増殖薬活性化受容体(PPAR)αアゴニストとしての置換フェニルプロピオン酸誘導体
CA2410338A1 (en) * 2000-05-22 2001-11-29 Takeda Chemical Industries, Ltd. Tyrosine phosphatase inhibitors
MY129000A (en) * 2000-08-31 2007-03-30 Tanabe Seiyaku Co INHIBITORS OF a4 MEDIATED CELL ADHESION
US7176204B2 (en) 2000-12-05 2007-02-13 Kyorin Pahrmaceutical Co., Ltd. Substituted carboxylic acid derivatives
CN1551866A (zh) * 2001-08-09 2004-12-01 СҰҩƷ��ҵ��ʽ���� 羧酸衍生物化合物及包含这些化合物为活性成分的药物
SE0201937D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab Therapeutic agents
ES2299702T3 (es) * 2002-06-20 2008-06-01 Astrazeneca Ab Derivados de acido benzoico orto-sustituidos para el tratamiento de la resistencia a la insulina.
RU2391340C2 (ru) * 2004-08-11 2010-06-10 Киорин Фармасьютикал Ко., Лтд. Новое циклическое производное аминобензойной кислоты
US8101774B2 (en) * 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof

Also Published As

Publication number Publication date
FR2307528B1 (enExample) 1981-11-13
DK148576A (da) 1976-10-19
AT345795B (de) 1978-10-10
PT65019A (de) 1976-05-01
ES446976A1 (es) 1977-06-01
RO73520A (ro) 1980-12-30
FI761004A7 (enExample) 1976-10-19
ATA283676A (de) 1978-02-15
SE423231B (sv) 1982-04-26
HU177559B (en) 1981-11-28
NL7603947A (nl) 1976-10-20
CA1047513A (en) 1979-01-30
SU618038A3 (ru) 1978-07-30
IE42712L (en) 1976-10-18
BG26518A3 (bg) 1979-04-12
FR2307528A1 (fr) 1976-11-12
AU497513B2 (en) 1978-12-14
IE42712B1 (en) 1980-10-08
AR213174A1 (es) 1978-12-29
SE7604381L (sv) 1976-10-19
IL49411A0 (en) 1976-06-30
US4113871A (en) 1978-09-12
GB1484848A (en) 1977-09-08
DD124974A5 (enExample) 1977-03-23
PT65019B (de) 1977-09-09
AU1315776A (en) 1977-10-27
LU74786A1 (enExample) 1977-01-12
JPS51136646A (en) 1976-11-26
IL49411A (en) 1979-12-30

Similar Documents

Publication Publication Date Title
PL101299B1 (pl) Sposob wytwarzania pochodnych kwasu fenyloalkanokarboksylowego
SU1052157A3 (ru) Способ получени производных феноксиалкилкарбоновой кислоты,их солей,сложных эфиров и амидов
US4238506A (en) Hypoglycaemically and hypolipidaemically active derivatives of phenyl-alkane-carboxylic acids
JP5000683B2 (ja) 置換フェニルアルカン酸誘導体及びその用途
EP0126030A2 (de) Verfahren zur Herstellung von beta-(Benzthiazolylthio)- und beta-(Benzimidazolylthio)-carbonsäuren
EP3594221B1 (en) Gpr84 receptor antagonist and use thereof
PL173677B1 (pl) Amidy kwasów sulfonamido-i sulfonamidokarbonylo-pirydyno-2-karboksylowych
AU593039B2 (en) Phenoxyalkylcarboxylic acids and esters and their preparation and pharmaceutical formulation
EP0239907B1 (de) Neue Phenoxyalkylcarbonsäure-Derivate, Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende Arzneimittel
DK152494B (da) Analogifremgangsmaade til fremstilling af thiazolidin-, morpholin- og thiazanderivater eller fysiologisk acceptable salte deraf
PL126032B1 (en) Process for preparing novel derivatives of 5-phenyl-2-hydroxytetrahydrofuran
DK153545B (da) Analogifremgangsmaade til fremstilling af n-substituerede derivater af 3,4,5-trihydroxy-2-hydroxymethyl-piperidin
EP0618899B1 (en) Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase
EP0179254A1 (en) 4,5-Dihydro-4-oxo-2- [(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof
US6509362B2 (en) N-phenylamide and N-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them
US4130658A (en) Novel phenethylamines
NO170013B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-t-butylfenoler substituert med alkoxy- eller benzyloxygruppe eller en benzylthiogrupp
DK155009B (da) Analogifremgangsmaade til fremstilling af thienooe2,3-eaa-1,2-thiazin-1,1-dioxidderivat eller farmaceutisk tolerable salte heraf samt udgangsmateriale til brug ved fremgangsmaaden
GB2146982A (en) New 1,3,4-thiadiazole derivatives process for the production thereof and pharmaceutical compositions having antiulcer activity containing the same
KR19990082986A (ko) 장애 설폰아미드를 알킬화시키는 방법
PL110872B1 (en) Method of manufacture of novel 4-substituted 3-sulfamoyl-5-pyrrolylalkylbenzoic acids
CH622777A5 (enExample)
CS216205B2 (en) Method of making the derivatives of the 1,4-diphenylpyrazole
PL161322B1 (pl) Sposób wytwarzania nowych sulfonamidów z grupa tetrazolilowa PL PL PL
PL85216B1 (enExample)